Skip to main content
TipRanks
Go Ultimate75% OFF

PharmaResearch Co., Ltd. (214450) Ownership - Who Owns PharmaResearch Co., Ltd.?

PharmaResearch Co., Ltd. (214450) Ownership Overview

  • 2.41% Mutual Funds
  • 4.20% ETFs
  • 93.39% Public Companies and Individual Investors

The ownership structure of PharmaResearch Co., Ltd. (KR:214450) stock is a mix of institutional, retail, and individual investors. Approximately 6.61% of the company’s stock is owned by Institutional Investors, and 93.39% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

KR:214450 top shareholders
Holder# of SharesType% HoldingValue
Vanguard208,108Institution2.00%39,117,645
Ishares150,447Institution1.45%28,279,222
Vanguard Star Funds99,108Institution0.95%18,629,133
Vanguard Tax-managed Funds66,066Institution0.64%12,418,294
Vanguard International Equity Index Funds40,064Institution0.39%7,530,750
Dfa Investment Dimensions Group Inc30,692Institution0.30%5,769,114
Avantis24,696Institution0.24%4,642,058
Dimensional23,461Institution0.23%4,409,917
Schwab14,048Institution0.14%2,640,574
State Street7,987Institution0.08%1,501,300

Top Mutual Fund Holders

KR:214450 top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Star Funds99,108Institution0.95%18,629,133
Vanguard Tax-managed Funds66,066Institution0.64%12,418,294
Vanguard International Equity Index Funds40,064Institution0.39%7,530,750
Dfa Investment Dimensions Group Inc30,692Institution0.30%5,769,114
Fidelity Salem Street Trust4,584Institution0.04%861,645
State Street Institutional Investment Trust3,043Institution0.03%571,987
Victory Portfolios Iii1,911Institution0.02%359,207
American Century Etf Trust1,844Institution0.02%346,613
Fidelity Concord Street Trust1,795Institution0.02%337,403
Calvert World Values Fund, Inc.900Institution<0.01%169,171

Top ETF Holders

KR:214450 top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total International Stock ETF, VXUS ETF99,974Institution0.96%22,806,253
iShares Core MSCI Emerging Markets ETF, IEMG ETF79,249Institution0.76%14,828,915
Vanguard FTSE Developed Markets ETF, VEA ETF66,066Institution0.64%15,071,090
Vanguard FTSE All-World ex-US Small-Cap ETF, VSS ETF24,857Institution0.24%5,670,422
Avantis Emerging Markets Equity ETF, AVEM ETF22,522Institution0.22%4,189,882
Schwab International Small-Cap Equity ETF, SCHC ETF14,048Institution0.14%2,613,311
iShares Core MSCI Total International Stock ETF, IXUS ETF10,606Institution0.10%1,984,574
Dimensional Emerging Markets Core Equity 2 ETF, DFEM ETF9,499Institution0.09%1,768,478
SPDR Portfolio Developed World ex-US ETF, SPDW ETF7,662Institution0.07%1,425,341
Vanguard FTSE Pacific ETF, VPL ETF7,223Institution0.07%1,647,723

FAQ

What percentage of PharmaResearch Co., Ltd. (KR:214450) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.61% of PharmaResearch Co., Ltd. (KR:214450) stock is held by institutional investors: 2.41% by mutual funds and 4.20% by ETFs.
What percentage of PharmaResearch Co., Ltd. (KR:214450) stock is held by retail investors?
According to the latest TipRanks data, approximately 93.39% of PharmaResearch Co., Ltd. (KR:214450) stock is held by public companies and individual investors.
Who owns the most shares of PharmaResearch Co., Ltd. (KR:214450)?
Vanguard owns the most shares of PharmaResearch Co., Ltd. (KR:214450).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.